Microbe vaccine looks promising
From Times Staff and Wire Reports
A vaccine to prevent a dangerous infection that often strikes cystic fibrosis patients is feasible but needs more development, German researchers reported Monday in the Proceedings of the National Academy of Sciences.
About 80% of CF patients become infected with the life-threatening Pseudomonas aeruginosa microbe. The experimental vaccine reduced infections by a third, according to researchers from the University of Tuebingen. They said the vaccine would be more effective if it targeted more of the P. aeruginosa strains that produce disease.
